Joinn Laboratories (06127): Abnormal fluctuations in A shares trading of the company with no undisclosed major information that should have been disclosed.
Zhao Yan New Medicine (06127) announced that the closing price of the company's A shares exceeded 20% of the deviation value for three consecutive trading days on March 27, March 30, and March 31, 2026. According to the relevant provisions of the Shanghai Stock Exchange Trading Rules, this situation constitutes abnormal stock trading volatility.
Joinn Laboratories (06127) announced that the closing price of the company's A shares deviated by more than 20% for three consecutive trading days on March 27, March 30, and March 31, 2026. According to the relevant regulations of the Shanghai Stock Exchange trading rules, this constitutes abnormal fluctuation in the stock trading.
After conducting self-inspection and written inquiries to the company's controlling shareholder and actual controller, as of the date of this announcement, the company, its controlling shareholder, and actual controller confirmed that there is no material information that should be disclosed but has not been disclosed.
Related Articles

WASION HOLDINGS (03393) subsidiary wins contract for approximately 462,000 smart meters from State Grid, with a contract value of around 97.66 million yuan.

RAINMED-B (02297) released its performance for the year 2025, with a net loss attributable to shareholders of 77.083 million yuan, a year-on-year narrowing of 32.1%.

NETEASE MUSIC (09899) spent 14.9978 million Hong Kong dollars on March 31 to repurchase 11.62 thousand shares.
WASION HOLDINGS (03393) subsidiary wins contract for approximately 462,000 smart meters from State Grid, with a contract value of around 97.66 million yuan.

RAINMED-B (02297) released its performance for the year 2025, with a net loss attributable to shareholders of 77.083 million yuan, a year-on-year narrowing of 32.1%.

NETEASE MUSIC (09899) spent 14.9978 million Hong Kong dollars on March 31 to repurchase 11.62 thousand shares.

RECOMMEND

Chinese Innovative Drug Assets Attract Major Foreign Acquisition, Cooperation Models Diversify
26/03/2026

Four Giants Subscribe As Memory Manufacturer Confirms TWD 78.718 Billion Private Placement For Capacity Expansion
26/03/2026

Year‑On‑Year Surge Exceeding 500%: Hong Kong IPOs Top HKD 100 Billion This Year
26/03/2026


